Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Yahoo/PR NewsWire
Saturday, February 20, 2010 - 11:40am
tags:
Amgen, Prolia
Life Technologies Announces Completion of $1.5 Billion Senior Notes Offering
Yahoo/BusinessWire
Saturday, February 20, 2010 - 11:39am
tags:
Life Technologies
La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote
Yahoo/BusinessWire
Saturday, February 20, 2010 - 11:37am
tags:
La Jolla Pharmaceutical, Adamis Pharmaceuticals, M&A
Biogen drug OK'd for leukemia treatment
bizjournals.com
Saturday, February 20, 2010 - 11:01am
tags:
Biogen Idec, Rituxan, Genentech, leukemia
Drug stocks turn higher; Shire, XenoPort gain
MarketWatch
Saturday, February 20, 2010 - 10:58am
tags:
Shire, XenoPort
Novavax says swine flu vaccine works
bizjournals.com
Saturday, February 20, 2010 - 10:57am
tags:
Novavax, swine flu
Pharma's Mega-Deals No Tonic For R&D
Yahoo/Investor's Business Daily
Saturday, February 20, 2010 - 10:55am
tags:
R&D
Summary Box: J&J cuts Swiss partner, MRSA rights
Yahoo/AP
Saturday, February 20, 2010 - 10:53am
tags:
JNJ, MRSA, Basilea
Breathe Deep. It Might Not Be That Bad. (FDA and asthma drugs)
Motley Fool
Saturday, February 20, 2010 - 10:52am
tags:
long acting beta agonists, Merck, Novartis, GSK, AstraZeneca
DHS extends GenVec vaccine contract
bizjournals.com
Saturday, February 20, 2010 - 10:48am
tags:
GenVec
Attention-Deficit Drug Maker Shire Up 5% on Blow-Out Q4; Outlook in Line
Barron's
Saturday, February 20, 2010 - 10:48am
tags:
Shire, ADHD, Adderall
Abbott Labs hikes quarterly dividend by 10%
MarketWatch
Saturday, February 20, 2010 - 10:47am
tags:
Abbott Laboratories
Does India Want Drug Innovation or Not?
WSJ
Saturday, February 20, 2010 - 10:47am
tags:
India, innovation
Drug stocks slip; Shire climbs on earnings report
Marketwatch
Friday, February 19, 2010 - 10:53am
tags:
drug stocks, Shire
Healthcare a Focus for Big Moves by Icahn
Yahoo/Indie Research
Friday, February 19, 2010 - 10:51am
tags:
Carl Icahn, Biogen Idec, Amylin, Genzyme, Forest Labs, Exelixis
Sepracor merges and CEO Adams jumps to Inspire
Fierce Biotech
Friday, February 19, 2010 - 10:49am
tags:
Sepracor, Inspire
New York Bill On Gardasil Vaccination On Hold
Pharmalot
Friday, February 19, 2010 - 10:48am
tags:
New York, Gardasil, vaccines, HPV, Merck
Obama takes new tack on healthcare reform
Fierce Pharma
Friday, February 19, 2010 - 10:47am
tags:
Obama, healthcare reform
FDA Boasts About Approvals Of Cancer Drugs
Pharmalot
Friday, February 19, 2010 - 10:44am
tags:
FDA, cancer
ARYx cuts staff, explores future options
Bizjournals.com
Friday, February 19, 2010 - 10:29am
tags:
ARYx, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.